Abstract
A controversial bill to change the classification of the opioid hydrocodone from Schedule II to Schedule II might help decrease the incidence of drug abuse through stricter regulation of Schedule II products, or, as some groups claim, it might hinder access for patients with legitimate prescriptions.
Links
Authors
Source
P & T : a peer-reviewed journal for formulary management 37:7 2012 Jul pg 399-404Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22876104
Log In

